High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer

Estrogen receptor-positive (ER+) breast cancer intrinsically confers satisfactory clinical outcomes in response to endocrine therapy. However, a significant proportion of patients with ER+ breast cancer do not respond well to this treatment. Therefore, to evaluate the effects of endocrine therapy, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Onaga, Chotaro, Tamori, Shoma, Matsuoka, Izumi, Ozaki, Ayaka, Motomura, Hitomi, Nagashima, Yuka, Sato, Tsugumichi, Sato, Keiko, Xiong, Yuyun, Sasaki, Kazunori, Ohno, Shigeo, Akimoto, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126382/
https://www.ncbi.nlm.nih.gov/pubmed/35605014
http://dx.doi.org/10.1371/journal.pone.0268799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126382/
https://www.ncbi.nlm.nih.gov/pubmed/35605014
http://dx.doi.org/10.1371/journal.pone.0268799

Ejemplares similares